Edward J. Glamkowski

449 total citations
22 papers, 334 citations indexed

About

Edward J. Glamkowski is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Edward J. Glamkowski has authored 22 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 8 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Edward J. Glamkowski's work include Synthesis and pharmacology of benzodiazepine derivatives (9 papers), Synthesis and Reactivity of Heterocycles (4 papers) and Chemical synthesis and alkaloids (4 papers). Edward J. Glamkowski is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (9 papers), Synthesis and Reactivity of Heterocycles (4 papers) and Chemical synthesis and alkaloids (4 papers). Edward J. Glamkowski collaborates with scholars based in United States and Canada. Edward J. Glamkowski's co-authors include Daniel B. Ellis, M. Sletzinger, James M. Fortunato, Joseph T. Strupczewski, Alan J. Davidson, R. M. PURICK, Jeffrey C. Wilker, Richard C. Allen, Francis P. Huger and Mark R. Szewczak and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Edward J. Glamkowski

22 papers receiving 301 citations

Peers

Edward J. Glamkowski

CMN

PHARM

Jiban K. Chakrabarti United States

J. METYSOVA Czechia

Seymour D. Levine Malaysia

Cyrus J. Ohnmacht United States

R. R. Crenshaw United States

G. S. Sach Italy

Klaus P. Boegesoe Denmark

Fred M. Hershenson United States

Pawel Fludzinski United States

Ronald J. McCaully United States

Jiban K. Chakrabarti United States

Edward J. Glamkowski

265 ×1.1

114 ×1.1

28 ×0.8

CMN

15 ×0.6

21 ×0.9

PHARM

Citations per year, relative to Edward J. Glamkowski Edward J. Glamkowski (= 1×) peers Jiban K. Chakrabarti

Countries citing papers authored by Edward J. Glamkowski

Since Specialization

Citations

This map shows the geographic impact of Edward J. Glamkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Glamkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Glamkowski more than expected).

Fields of papers citing papers by Edward J. Glamkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Glamkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Glamkowski. The network helps show where Edward J. Glamkowski may publish in the future.

Co-authorship network of co-authors of Edward J. Glamkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Glamkowski. A scholar is included among the top collaborators of Edward J. Glamkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Glamkowski. Edward J. Glamkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strupczewski, Joseph T., Edward J. Glamkowski, Paul Conway, et al.. (1995). 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-Benzisoxazoles as D2/5-HT2 Antagonists with Potential Atypical Antipsychotic Activity: Antipsychotic Profile of Iloperidone (HP 873). Journal of Medicinal Chemistry. 38(7). 1119–1131. 66 indexed citations

Huger, Francis P., et al.. (1987). Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 2. In vitro profile. Drug Development Research. 11(3-4). 169–175. 7 indexed citations

Glamkowski, Edward J., et al.. (1987). Tetracyclic benzodiazepines. 4. Synthesis of the novel benzo[c]pyrrolo[1,2,3‐ef][1,5]benzodiazepine ring system, and derivatives with potential antipsychotic activity. Journal of Heterocyclic Chemistry. 24(6). 1599–1604. 8 indexed citations

Szewczak, Mark R., Michael L. Cornfeldt, Robert W. Dunn, et al.. (1987). Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profile. Drug Development Research. 11(3-4). 157–168. 9 indexed citations

Strupczewski, Joseph T., Richard C. Allen, Edward J. Glamkowski, et al.. (1985). Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles. Journal of Medicinal Chemistry. 28(6). 761–769. 63 indexed citations

Glamkowski, Edward J., et al.. (1984). Novel tetracyclic spiropiperidines. 4. Synthesis and pharmacological evaluation of spiro- and 6,7-dihydrospiro[benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepine-2H(1H),4'-piperidine]s. Journal of Medicinal Chemistry. 27(1). 81–83. 10 indexed citations

Glamkowski, Edward J., et al.. (1984). Synthesis of 7‐substituted 1H‐indolo[3,2‐d][1,2]benzoxazepines. Journal of Heterocyclic Chemistry. 21(5). 1257–1259. 4 indexed citations

Ong, Helen H., James A. Profitt, James M. Fortunato, et al.. (1983). Novel tetracyclic spiropiperidines. 3. 1-Arylspiro[indoline-3,4'-piperidine]s as potential antidepressants. Journal of Medicinal Chemistry. 26(7). 981–986. 11 indexed citations

Glamkowski, Edward J., et al.. (1980). 7-(Aminoacyl) and 7-(aminoalkyl) derivatives of 1,2,6,7-tetrahydroindolo[1,7-ab][1,5]benzodiazepines as potential antidepressant agents. Journal of Medicinal Chemistry. 23(12). 1380–1386. 9 indexed citations

10.

Glamkowski, Edward J. & James M. Fortunato. (1979). Synthesis of 1,2‐dihydroindolo [1,7‐AB] [1,5] benzodiazepines and related structures. A new heterocyclic ring system. Journal of Heterocyclic Chemistry. 16(5). 865–869. 4 indexed citations

11.

Glamkowski, Edward J., et al.. (1979). Synthesis and evaluation for diuretic activity of 1-substituted 6-chloro-5-sulfamylindolines. Journal of Medicinal Chemistry. 22(1). 106–109. 13 indexed citations

12.

Glamkowski, Edward J., et al.. (1978). Synthesis and Evaluation of 3-Substituted l-[4-(2-Indol-3-ylethyl)piperazinyl]ureas as Potential Antihypertensive Agents. Journal of Pharmaceutical Sciences. 67(12). 1773–1774. 1 indexed citations

13.

Glamkowski, Edward J., et al.. (1977). Synthesis of 3-(4-acylaminopiperazin-1-ylalkyl)indoles as potential antihypertensive agents. Journal of Medicinal Chemistry. 20(11). 1485–1489. 5 indexed citations

14.

Glamkowski, Edward J., et al.. (1974). Antihypertensive activity of 1-dimethylphosphinylmethyl-4-arylpiperazines. Journal of Medicinal Chemistry. 17(9). 1008–1009. 6 indexed citations

15.

Glamkowski, Edward J., et al.. (1973). Aldehyde analog of indomethacin. Journal of Medicinal Chemistry. 16(2). 176–177. 4 indexed citations

16.

Glamkowski, Edward J., et al.. (1970). New synthesis of the antibiotic phosphonomycin. The Journal of Organic Chemistry. 35(10). 3510–3512. 55 indexed citations

17.

Glamkowski, Edward J., et al.. (1967). A New Class of Potent Decarboxylase Inhibitors. β-(3-Indolyl)-α-hydrazinopropionic Acids. Journal of Medicinal Chemistry. 10(5). 852–855. 11 indexed citations

18.

Cava, Michael P., et al.. (1967). Steroids. VII. The synthesis and reactions of some .alpha.,.beta.-unsaturated .alpha.1-oximino-3-oxo steroids. The Journal of Organic Chemistry. 32(8). 2644–2647. 3 indexed citations

19.

Cava, Michael P., Edward J. Glamkowski, & Philip M. Weintraub. (1966). Steroids. VI. The Synthesis and Reactions of Some 2,4-Bisoximino-3-keto Steroids^1a. The Journal of Organic Chemistry. 31(9). 2755–2758. 4 indexed citations

20.

Cava, Michael P., Philip M. Weintraub, & Edward J. Glamkowski. (1966). Steroids. V. 2β-Carboxy-A-norcholestane¹. The Journal of Organic Chemistry. 31(6). 2015–2017. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact